Find uplifting stories about heroes, innovations, and solutions
1239 results for "** dengue vaccine"
India just approved Qdenga, its first dengue vaccine that protects against all four types of the virus. More than 40 countries already use the vaccine, bringing new hope to a nation where dengue affects millions each year.
A global research team just launched an €11 million project to bring a single-dose dengue vaccine to sub-Saharan Africa, where climate change is driving a surge in infections. The four-year initiative could protect millions from the mosquito-borne disease that's becoming a growing health threat across the continent.
India just approved its first dengue vaccine that works against all four virus strains, no pre-test needed. The shot protects 84% against hospitalization and could produce 50 million doses annually in India alone.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
Sudan's Ministry of Health is ramping up vaccination campaigns to combat multiple disease outbreaks, including dengue fever and hepatitis. Health officials are using existing immunization programs to spread life-saving awareness across communities.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
A routine vaccine millions get for shingles might be doing something remarkable: protecting hearts for years afterward. New research on 70,000 Americans reveals an unexpected health bonus that could change how we think about vaccines.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
A tetanus-diphtheria vaccine that stays effective for two years without refrigeration has passed its first human safety trial. The breakthrough could help vaccines reach millions in remote areas where keeping medicines cold is nearly impossible.
The same groundbreaking technology that created COVID vaccines just earned approval for fighting the flu. Moderna's new mRNA flu shot showed better protection than standard vaccines and will be available for the 2026-2027 flu season.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
Showing 20 of 1239